| Net Cash Provided by (Used in) Operating Activities |
$14,524,000 |
USD |
-520% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$2,568,000 |
USD |
178% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$16,000 |
USD |
-111% |
Q2 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$2,336,000 |
USD |
-3.8% |
Q3 2025 |
Q2 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$35,000 |
USD |
-85% |
Q2 2025 |
Q1 2026 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q2 2025 |
Q1 2026 |
| Operating Lease, Liability |
$553,000 |
USD |
-14% |
Q3 2025 |
Q2 2026 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$1,212,000 |
USD |
94% |
Q3 2025 |
Q2 2026 |
| Lessee, Operating Lease, Liability, to be Paid |
$565,000 |
USD |
-16% |
Q3 2025 |
Q2 2026 |
| Operating Lease, Liability, Current |
$293,000 |
USD |
7.3% |
Q3 2025 |
Q2 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$105,000 |
USD |
-50% |
Q3 2025 |
Q2 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$310,000 |
USD |
55% |
Q3 2025 |
Q2 2026 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.03 |
pure |
0% |
Q1 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$12,000 |
USD |
-59% |
Q3 2025 |
Q2 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$72,000 |
USD |
-66% |
Q1 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$16,216,000 |
USD |
-23% |
Q1 2025 |
FY 2025 |
| Current Income Tax Expense (Benefit) |
$20,000 |
USD |
233% |
Q3 2025 |
Q2 2026 |
| Preferred Stock, Shares Authorized |
15,000,000 |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
$72,000 |
USD |
5.9% |
Q2 2024 |
Q1 2025 |
| Additional Paid in Capital |
$557,994,000 |
USD |
2% |
Q3 2025 |
Q2 2026 |
| Depreciation, Depletion and Amortization |
$1,062,000 |
USD |
23% |
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$31,294,000 |
USD |
-25% |
Q1 2025 |
FY 2025 |
| Interest Expense |
$4,365,000 |
USD |
309% |
Q1 2025 |
FY 2025 |